Transcatheter aortic valve replacement (TAVR) has become a well-accepted option for
treating patients with aortic stenosis at intermediate to high or prohibitive surgical risk. TAVR …

The introduction of devices for transcatheter aortic valve implantation, mitral repair, and
closure of prosthetic paravalvular leaks has led to a greatly expanded armamentarium of …

After publication, dissemination of the message is of paramount importance. Pocket-sized
versions and personal digital assistant (PDA) downloadable versions are useful at the point …

Background The use of transcatheter aortic-valve replacement has been shown to reduce
mortality among high-risk patients with aortic stenosis who are not candidates for surgical …

Background Many patients with severe aortic stenosis and coexisting conditions are not
candidates for surgical replacement of the aortic valve. Recently, transcatheter aortic-valve …

Objectives: To propose standardized consensus definitions for important clinical endpoints
in transcatheter aortic valve implantation (TAVI), investigations in an effort to improve the …

Background—There is a lack of information on the incidence and predictors of early mortality
at 30 days and late mortality between 30 days and 1 year after transcatheter aortic valve …

Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …

Objectives: This study sought to perform a weighted meta-analysis to determine the rates of
major outcomes after transcatheter aortic valve replacement (TAVR) using Valve Academic …

Background Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for
the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We …